<DOC>
	<DOCNO>NCT02082886</DOCNO>
	<brief_summary>In registry study investigator collect data patient ' disease , treatment , response treatment include local national database . These used investigator answer question cytoreductive surgery/HIPEC well-tolerated effective specific population .</brief_summary>
	<brief_title>HIPEC For Peritoneal Surface Malignancies Including Carcinomatosis Sarcomatosis ‚Äê Data Registry</brief_title>
	<detailed_description>Patient Selection : The sole inclusion criterion study consent patient undergo cytoreductive surgery follow HIPEC . Data Collection Use Plan : For patient provide informed consent , data list collected treatment . This enter PI 's local database future use , de-identified , share national database ( held American Society Peritoneal Surface Malignancies ) bolster amount available researcher look efficacy outcome overall survival rate , progression-free survival , tolerability certain population . Data Collected ( applicable ) : Age , primary tumor , date prior surgery , prior chemotherapy date whether neoadjuvant nature , length disease status , comorbidities , Peritoneal Surface Disease Severity Score , Peritoneal Cancer Index determine prior surgery , Peritoneal Cancer Index determine surgery , Completeness Cytoreduction score , ascites present , blood product use , complication , length stay ICU hospital , discharge , death within 30 day , readmission reason , date recurrence , treatment recurrence , time procedure death . For HIPEC surgical procedure , data collect : date , duration , chemotherapeutic use dose , duration circulation , fluid temp , flow rate .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<criteria>Eligible undergo cytoreductive surgery follow HIPEC perform PI Edward Hospital Provides consent signing informed consent form Not eligible surgery potential cytoreductive surgery and/or HIPEC determine PI Does consent participate</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Metastasis</keyword>
	<keyword>Carcinomatosis</keyword>
	<keyword>Carcinosis</keyword>
	<keyword>Sarcomatosis</keyword>
	<keyword>CRS</keyword>
	<keyword>Cytoreductive surgery</keyword>
	<keyword>HIPEC</keyword>
	<keyword>Heated Intraperitoneal Chemotherapy</keyword>
	<keyword>Intra-abdominal</keyword>
	<keyword>Sugarbaker technique</keyword>
	<keyword>Mitomycin C</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>Doxorubicin</keyword>
	<keyword>Oxaliplatin</keyword>
	<keyword>Melphalan</keyword>
</DOC>